Characterization of 2 Genetic Variants of Nav1.5-Arginine 689 Found in Patients with Cardiac Arrhythmias


  • The groups of E.V. Zaklyazminskaya and H. Abriel are supported by a grant for scientific cooperation between Eastern Europe and Switzerland by the Swiss National Science Foundation (SCOPES #IZ73Z0_128016). This work was also supported by a grant from the Swiss National Science Foundation to HA (310030B_135693). F. Jousset is supported by the European Union (European Network for Translational Research in Atrial Fibrillation (EUTRAF) FP7 grant).

  • No disclosures.

Address for correspondence: Hugues Abriel, M.D., Ph.D., University of Bern, Department of Clinical Research Murtenstrasse 35, 3010 Bern, Switzerland. Fax: 41-31-6320946; E-mail:

Nav1.5-Arg689 in Arrhythmias

Hundreds of genetic variants in SCN5A, the gene coding for the pore-forming subunit of the cardiac sodium channel, Nav1.5, have been described in patients with cardiac channelopathies as well as in individuals from control cohorts. The aim of this study was to characterize the biophysical properties of 2 naturally occurring Nav1.5 variants, p.R689H and p.R689C, found in patients with cardiac arrhythmias and in control individuals. In addition, this study was motivated by the finding of the variant p.R689H in a family with sudden cardiac death (SCD) in children.

When expressed in HEK293 cells, most of the sodium current (INa) biophysical properties of both variants were indistinguishable from the wild-type (WT) channels. In both cases, however, an ∼2-fold increase of the tetrodotoxin-sensitive late INa was observed. Action potential simulations and reconstruction of pseudo-ECGs demonstrated that such a subtle increase in the late INa may prolong the QT interval in a nonlinear fashion. In conclusion, despite the fact that the causality link between p.R689H and the phenotype of the studied family cannot be demonstrated, this study supports the notion that subtle alterations of Nav1.5 variants may increase the risk for cardiac arrhythmias.